Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The reason it's not is that there are less than 5 million shares in the float and less than 10 million shares OS. Any reasonable announcement of new revenue is bound to send this thing flying.
Let's take those one by one...
1.) mCig did not sign up to be a sponsor of FarmOn like the companies you mentioned. Those companies gave FarmOn a donation period. mCig and FarmOn signed a partnership agreement to do business together. One proof of that is that they formed a joint venture and the CEO of FarmOn became the CEO of the joint venture. Paul was following the business strategy that was predominant in California at the time were virtually all MJ companies were organized around non-profits. It allowed them to claim all the costs of growing as a cost of goods (i.e. inventory) since they would be purchasing the product (from the non profit) instead of growing it themselves (normal business expenses of MJ companies could not be claimed as a tax deduction).
2.) (I think you meant trial) We don't know that the crop failed. That was FarmOn's claim. However, they broke their contract and wouldn't let mCig reps on their property to verify what happened. mCig sued them but for all we know the crop could have been sold elsewhere (perhaps they thought they could get a better deal). In the meantime, judging by the number of licenses granted by the state and the fact that they were reporting, it's obvious that others were successfully growing hemp in the state.
3.) The pandemic was the last straw not the excuse. Shortly after the OBTX dividend was announced Alex Mardikian had set up partnerships with HaulTail and several other companies for digital advertising. Unfortunately, at about that time mCig's deal with FarmOn fell apart and their revenue expectations dried up. OBTX couldn't fund their partnership obligations since the SEC was dragging their feet in making them public and in the meantime, mCig couldn't offer any funding. Their partnership agreements dried up and OBTX was forced to wait for the SEC. They didn't get the OK to start trading until last April, in the middle of the pandemic. I don't think anyone would argue with the fact that the timing isn't optimal right now for kick starting a new company.
LMAO When was the last time your claims ended up being the real reason the pps went south. When the criticism is fair or accurate I let it go, but, it's all too easy to make baseless accusations about a company based on made up assumptions and misleading information.
LOL Fact is, this blog has little to no effect on the pps and I doubt there are many Europeans reading my posts. I just like to keep people like you somewhat honest.
SMHL How does having more European shareholders translate to a higher pps???? I was responding to your disparaging remark about Europeans controlling Bots' Facebook page to point out that Bot's was now trading on a European exchange. I made the observation that it might be an advantage if Europe's economy isn't as hard hit by the pandemic as the US economy is (i.e. there may be less downward pressure on the pps). That may be why Bot's pps has been trading in a relatively stable range roughly between $.025 and $.039/share.
Straw man argument. Why would anyone expect trading on a new exchange would result in a higher pps? No one made this claim.
Debunked Again!
SMHL You keep railing against Paul but he's not calling all the shots anymore. First Bitcoin now has voting control over the company. They recently set up a new Board of Directors. The Business Plan is now First Bitcoin's plan...
07/21/2020 BTZI 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 21, 2020, Yuri Abramov and Simon Rubin were appointed as the directors of the Board of Directors of BOTS, INC.
Simon Rubin and Yuri Abramov currently serve on the boards of public company, First Bitcoin Capital Corp.
Simon Rubin served as the Chairman of the Board of Directors of First Bitcoin Capital for the last 10 years. He is a serial entrepreneur with a background in programming and web design and Real Estate. Simon also has 15 years of experience in health care equipment management. Simon is an avid crypto currency enthusiast and martial arts expert.
Yuri Abramov has been director of First Bitcoin Capital since 2004. Master of Science in Theoretical Physics from the Institute of Chemical Physics, Russian Federation. For more than three decades, Yuri has applied his superior analytical skills and expertise to advance the field of applied physics in his work as a mathematician, algorithms and software developer, engineer and inventor. Yuri holds a Master of Science in Theoretical Physics and Chemical Physics from the Institute of Chemical Physics from the Russian Academy of Sciences in Moscow, Russia. Among his numerous unparalleled qualifications and credentials, Yuri is an expert problem solver in the areas of digital signal processing for video-compressions as well as for high speed wireless communications. Yuri is experienced in developing novel algorithms in MATLAB and C/C++ as well as SAW-filters hardware design, which are inherent attributes in many of today's state-of-the-art electronic systems and are developed to improve Tx-Rx Communication Systems by communication sensitivity. In addition, Yuri developed a SAW-coprocessor for wireless modems operating in UWB (ultra-wide band) frequency range that are destined for super-high-speed data communication. His business background includes acting as a projects leader for Soliton-SAW Ltd., for 14 years where he worked in consulting and implementation, algorithms and software development and modeling and designing.
I wasn't pushing any narrative for about the past year as it became apparent that mCig had abandoned the FarmOn project, ObitX wasn't going to get quick approval to go public and the pandemic set in.
They have a contract with a chinese factory which is supplying the initial production.
New PR is out...
Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update
MARINA DEL REY, Calif., Aug. 13, 2020 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced results for the second quarter of 2020 and provided a corporate and clinical update.
During the quarter, the Company announced a $15 million award from the U.S. Department of Defense, through the Medical Technology Enterprise Consortium (MTEC) with funding from the Defense Health Agency and Joint Warfighter Medical Research Program, for a three-year program to advance development of AP-SA02 in S. aureus bacteremia infections. Armata will use the award to partially fund a Phase 1b/2 randomized, double-blind, placebo-controlled, dose escalation clinical study. The Company expects to initiate the clinical trial next year.
"The highlight of the second quarter was our announcement of the $15 million award from the U.S. Department of Defense to advance AP-SA02, which we are developing as a potential treatment for Staphylococcus aureus bacteremia infections. In an ongoing effort to prudently manage our cash, we sought non-dilutive third-party funding to help advance this program, and we exceeded the amount that we were initially targeting. We are in the process of developing an efficient clinical plan for this promising candidate, and this award will now allow us to initiate a Phase 1b/2 clinical trial as expeditiously as possible," said Todd R. Patrick, Chief Executive Officer of Armata. "With respect to our lead program, subject to potential delays related to COVID-19, we believe we are on track to initiate our Phase 1b/2a clinical trial of AP-PA02 in Pseudomonas aeruginosa infections in cystic fibrosis patients later this year. Finally, we remain well capitalized with $19.8 million of cash on our balance sheet as of June 30, 2020."
Anticipated 2020 and 2021 Milestones:
Initiate a Phase 1b/2a clinical trial evaluating AP-PA02 as a potential treatment for Pseudomonas aeruginosa infections by the end of 2020
Initiate a Phase 1b/2 clinical trial evaluating AP-SA02 as a potential treatment for Staphylococcus aureus bacteremia infections in 2021
Continue to screen pathogens against the Company's proprietary phage library to identify additional high-quality bacteriophage product candidates and expand the pipeline.
Second Quarter Financial Results
Research and Development. Research and development expenses for the three months ended June 30, 2020 were approximately $2.6 million as compared to $3.1 million for the comparable period in 2019.
General and Administrative. General and administrative expenses for the three months ended June 30, 2020 were $2.0 million as compared to $2.1 million for the comparable period in 2019.
Loss from Operations. Loss from operations for the three months ended June 30, 2020 was $4.7 million as compared to $4.2 million for the comparable period in 2019.
Cash and Equivalents. As of June 30, 2020, Armata held $19.8 million of unrestricted cash and cash equivalents, as compared to $6.0 million as of December 31, 2019. Management believes the Company's existing resources will be sufficient to fund planned operations through at least the first half of 2021.
As of August 13, 2020, there were approximately 18.7 million shares of common stock outstanding.
About Armata Pharmaceuticals, Inc.
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, known as MSD outside of the United States and Canada, Armata is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Forward Looking Statements
This communication contains "forward-looking" statements, including, without limitation, statements related to Armata's ability to meet expected milestones, expand its pipeline, and pursue additional potential partnerships, the expected use of proceeds from the $15 million grant, the expected impact of the COVID-19 pandemic on the Company's operations, Armata's ability to be a leader in the development of phage-based therapeutics, and statements related to the timing and results of clinical trials, including the anticipated initiation of clinical trials of AP-PA02 and AP-SA02, Armata's ability to develop new products based on bacteriophages and synthetic phages, Armata's expectations for performance of Armata's therapeutic candidates based on Armata's recent nonclinical work, and Armata's ability to continue to screen pathogens against Armata's proprietary phage library to identify additional high-quality bacteriophage product candidates and expand the pipeline. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon Armata's current expectations. Forward-looking statements involve risks and uncertainties. Armata's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the ability of Armata's lead clinical candidates, AP-PA02 and AP-SA02, to be more effective than previous candidates; Armata's ability to expedite development of AP-PA02; Armata's ability to advance its preclinical and clinical programs and the uncertain and time-consuming regulatory approval process; Armata's ability to develop products based on bacteriophages and synthetic phages to kill bacterial pathogens; the Company's expected market opportunity for its products; Armata's ability to sufficiently fund its operations as expected, including obtaining additional funding as needed; and any delays or adverse events within, or outside of, Armata's control, caused by the recent outbreak of COVID-19. Additional risks and uncertainties relating to Armata and its business can be found under the caption "Risk Factors" and elsewhere in Armata's filings and reports with the SEC, including in Armata's Annual Report on Form 10-K, filed with the SEC on March 19, 2020, and in its subsequent filings with the SEC. Armata expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Armata's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
Media Contacts:
At Armata:
Steve Martin
Armata Pharmaceuticals, Inc.
ir@armatapharma.com
858-800-2492
Investor Relations:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com
212-915-2569
Hopefully, we'll see the first customer shipments in September or October.
That's a different company (too bad since they have over a billion dollars in assets). This company was co-founded by Yura Mitskevitch...
Elbrus Capital Group
Yura Mitskevich founded Elbrus Capital Group in 2010 and co-founded Elbrus Capital Markets in 2020 to provide turn key commercial real estate solutions to its clients and commercial real estate community.
Yura is currently responsible for the oversight and day-to-day operations of Elbrus Capital Markets (ECM) and Elbrus Capital Group (ECG) that is focused primarily on principal investments, investment sales and acquisitions and commercial real estate advisory services...
...Elbrus Capital Group is a privately held full service boutique commercial real estate services company that was founded in New York City, in 2010. Since then the company has engaged in numerous acquisitions and dispositions, capital raising, research and advisory and principal investment services on behalf of its clients. It also provides asset operational expertise, which includes: leasing and asset management services...
...Elbrus Capital Group provides institutional level real estate services to high net worth individuals, private family offices and small to mid-cap companies. ECG specializes in “off-market” transactions and identifies various investment opportunities for its clients.
This is an interesting and potentially lucrative new direction for their software team. By focusing on bank owned (e.g. foreclosure) real estate, Bot's can get a foothold on an important niche market. Here is some interesting background reading...
17 BLOCKCHAIN COMPANIES BOOSTING THE REAL ESTATE INDUSTRY
How Blockchain Technology is Changing Real Estate
There's a new PR out.
Bots, Inc. Awarded Contract to Build Blockchain Powered Real Estate Platform for Elbrus Capital Markets, LLC.
SAN JUAN, Puerto Rico, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BOTS, Inc. (OTC: BTZI) (GERMAN EXCHANGE: M06.SG), an emerging innovator of products, technologies, and services for the rapidly growing digital robotic automation and manufacturing industry announced today that Elbrus Capital Markets (ECM) has awarded an exclusive $400,000 contract for the Company to develop a Real Estate industry blockchain-powered supply chain management platform. The contract is contingent on ECM receiving additional funding from accredited investors unless Bots elects to receive partial or all payments in the equity ownership of ECM.
"Digital ledger technology is an integral part revolutionizing the whole process which is why we choose BOTS, Inc. to develop a streamlined process of real estate property ownership through a highly scalable blockchain-powered platform that will utilize machine learning and AI algorithms. BOTS, Inc. will bring our solutions to capture and move data, including ownership in mortgages, vaulting over an old-school industry exponentially faster. The platform will combine the benefits of a decentralized blockchain with the vast cumbersome paper trail in real estate transactions, enabling the digitization of real estate assets," stated Illia Pashkov, Co-Founder and Chief Technical Officer of Elbrus Capital Markets.
"Integration of the Blockchain into worldwide real estate industry applications expands the opportunities for investors. The bank-owned REO asset class is a great new pool for investors interested in buying property or real estate backed notes. ECM's real estate holdings utilizing blockchain transparency on a scalable core platform will allow investors to buy property or mortgage notes anywhere in the world without complex legal paperwork and other common hassles," commented Paul Rosenberg, CEO of BOTS, Inc.
Bots, Inc. will also build for ECM a smart contract system prototype on a blockchain to improve the efficiency of Real Estate chain management interactions. Taking advantage of distributed ledgers, the two companies will be exploring ways to optimize and monitor the supply chain logistics on the blockchain to automate the real estate industry transactions.
"We have begun a journey with Bots, Inc. to enhance our ability to scale and improve the potential of this new technology simultaneously. We are very pleased to collaborate and cooperate with their team and will begin to develop a first of its kind blockchain proof-of-concept. We look forward to seeing these blockchain applications applied to our business," stated Andrew Damian Forbes, Co-Founder, Chief Revenue Officer.
"Blockchain technology has the potential to change not only the real estate sector but also eliminates many inefficiencies which can be applied in countless other areas of the global business world, leading to improved and optimized efficiency of the end-to-end business transaction processes," said Bots, Inc. CEO Paul Rosenberg.
About ECM
See: www.elbruscapitalmarkets.com
We at ECM believe in helping investors build wealth through real estate. Historically earning passive income through real estate investments is considered one of the most stable methods for producing wealth. We ask our investors detailed questions about their goals and how we can help achieve those goals. We focus on several areas within the real estate markets in North America so that we can prioritize our efforts for our investors.
Our primary areas of focus are turnkey distressed multifamily rental properties, private money lending opportunities for land-development, vacation rental properties, and real estate education and technology.
About BOTS, Inc.
Headquartered in San Juan, Puerto Rico, BOTS, Inc. - publicly traded on the OTC Markets under the symbol (BTZI) and Börse Stuttgart under the ticker (M06.SG) - is a diversified company developing and servicing blockchain and robotics solutions for its clientele. The Company is committed to driving the innovations needed to shape the future of digital robotic automation management through digital technology and decentralized blockchain solutions. Management is dedicated to the strong growth of Distributed Asset Technology and Robotic Process Automation (RPA).
Shareholders, potential investors, and others should note that we announce material events and material financial information to our shareholders and the public using our website and the social media addresses listed below, as well as in our SEC filings, press releases, public conference calls, and webcasts. We also use social media to communicate with our subscribers and the public about our company, our services, and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage shareholders, the media, and others interested in our company to review the information we post on the U.S. social media channels listed below. This list may be updated from time to time.
Track BTZI news on Facebook @ https://www.facebook.com/Bots.Bz/
Follow BTZI news on Twitter @Bots_bz www.Twitter.com/Bots_bz
Find BTZI news at http://www.bots.bz
Bots, Inc. has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com.
For more information, visit http://www.bots.bz
Visit BTZI on Facebook https://www.facebook.com/Bots.Bz/
Follow BTZI on Twitter @Bots_bz
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as may be disclosed in the company's filings. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. Such forward-looking statements are risks that are detailed in the Company's website and filings.
Contact:
Paul Rosenberg
CEO
paul@bots.bz
Source: Bots, Inc.
You're the one being played. This is a fake study. Look at the website. It was created specifically to display this study. It's not being published in a respected medical journal like all valid studies are. You can't simply compare countries without getting into specifics about the number of patients in each country, how many were specifically treated with HCQ versus other treatments or no treatment, compared to the same variables in other countries.
The Russians are playing you chump. They're trying to make Trump look good. Trump's own FDA says it's useless and not safe. Check out some real studies published in real academic journals...
HCQ Studies showing no benefit to HCQ
Personal information is unavoidable. They'll have to file 1099's for tax purposes just like any broker would. Like any brokerage, crypto exchanges are becoming more and more subject to government regulations which would include privacy and fiduciary rules...
The US Cryptocurrency Landscape Is Changing - Here's What You Need To Know
BTZI has indicated what they expect...
BOTS, INC. TO REPURPOSE THE FIRST BITCOIN CRYPTOCURRENCY “BIT” AND USE IT TO PAY AN INCOME PRODUCING ASSET AS DIVIDEND TO SHAREHOLDERS
Once the name of BIT is changed to Basic Income Token, Bots Inc. intends to distribute 1 BIT for each share of Bots Inc. to be held on a record date to be set for distribution as soon as August 30, 2020.
Based on what I've read, all shareholders would be required to download or subscribe to a digital wallet to hold your tokens and to a digital exchange to trade them. Bots has acquired CoinQX exchange, which includes a trading platform and wallet to store your tokens. This would operate completely independent from your current broker and brokerage account.
Think of these tokens as shares of stock which is the way the SEC is viewing them and the exchange as the equivalent of the OTC, except in this case the exchange will also be storing your tokens (like your broker). I imagine Bot's will release a digital bot (program) to automatically subscribe shareholders to the new exchange and help them manage their wallet and trades. You'll be able to buy and sell your BIT tokens or trade them for other cryptocurrencies.
I imagine to keep your wallet open you would need to click on a link in your bot and keep your computer running so that it can record token transactions (it may also require a minimum amount of disk space). Bots could make money by charging a transaction fee on trades and perhaps selling advertising on the exchange and the bots. You would make money from creating new tokens (which will reward you with a fee) the frequency of which will be based on the number of tokens you own.
Moreover, Bots plans to distribute cryptocurrency ATM's which will also utilize the exchange to turn cash into tokens and vice versa. There are millions of people in this country and elsewhere who don't have access to the traditional banking community (think payday loans and check cashing businesses). They could make use of a cryptocurrency ATM as a banking substitute, potentially saving them millions in loan sharking interest payments.
One of the main beauties of this strategy is that it, along with the Universal Income Token (UIT), introduces thousands (and eventually millions) of people to owning and trading cryptocurrencies, which ultimately increases the value of those currencies for everyone.
Again, this is just my opinion based on what info has been released so far. The actual implementation may be very different from what I described.
NB: There was a typo on my previous post. I expect financial valuation of the First Bitcoin acquisition on the 1FQ21 (not 2FQ21) 10-Q due in mid September.
You need money to make money and mCig had them on a short leash while mcig was facing its own revenue problems. Combine that with the uncertainty of whether they'd be able to raise money by issuing stock next month or next year, and you don't have much opportunity for moving forward with any kind of business plan. Moreover, their precarious position would be a disincentive for any customers to sign a long term contract of any kind.
People haven't figured out how to value this yet. This may change after the 2FQ21 10-Q financials are published around mid September (if not sooner - it will include valuation of the First Bitcoin acquisition).
Time to update that number Rat. BIT is currently trading at $0.010168. That means our BIT dividend is currently worth roughly $.010168/share (or $101.68 for every 10,000 shares you own).
Coinmarketcap.com - First Bitcoin BIT
Let's see, 10,000 shares of BTZI at today's closing price of $.0325 would cost $325. Hmmm.
That doesn't do the company much good if a large part their target customers are consumer facing businesses like retail stores or restaurants. Until we see their business plan we just don't know how the pandemic is affecting them.
What is your problem with the ATM's. mCig/Bots owed Paul money. Paul accepted the ATM's as payment. Shareholders benefited from that. Paul is now selling the ATM's to companies that expect to use them with their cryptocurrency. How exactly is this a scam? Where is the harm to shareholders?
They probably don't physically exist
On June 3, 2019 MCIG purchased all cryptocurrency-based automated teller machines from OBITX for the price of $408,166 as part of a reduction of debt owed by OBITX to MCIG. Subsequently MCIG sold the assets to Paul Rosenberg in exchange for a $408,166 reduction to the debt owed, which loan agreement expired. In addition to the purchase of the ATM machines, the Company reduced the debt owed to Paul Rosenberg further by transferring a parcel of land owned by the Company in California in exchange for a further reduction of $235,000. In exchange, Mr. Rosenberg extended the terms of the agreement for an additional period of time.
Hawkins needs to figure out how to make ObitX a success or he's going to have a big tax headache by April 2023 (since the stock is restricted for two years). He'll have to claim $40,137,788 in earned income at that time ($14,000,000+ tax due at 37% tax bracket). The stock was granted at an average price of $5.35/share. At $1/share he could only sell those shares for roughly $7,500,000.
I'd say he has plenty of incentive to increase the pps, - and don't say he can just sell his shares on a pump. As CEO he has to report the sale plus, OBTX has not sold more than 37,000 shares in a single day since it went public (there are currently only roughly 5 million shares OS). Even if he tried, he'd take years to sell all his shares at that volume and probably lose a ton of money.
So when people tell you he's going to take investor money, ask them how.
Hawkins took over the company on April 17, 2020. The financials are reported through April 30. Considering the pandemic, Hawkins hasn't had much chance to do anything yet. I'd at least give him a couple of quarters to develop and start executing a business plan.
He needs to figure it out or he's going to have a big tax headache by April 2023 (since the stock is restricted for two years). He'll have to claim $40,137,788 in earned income at that time ($14,000,000+ tax due at 37% tax bracket). The stock was granted at an average price of $5.35/share. At $1/share he could only sell those shares for roughly $7,500,000.
I'd say he has plenty of incentive to increase the pps, - and don't say he can just sell his shares on a pump. As CEO he has to report the sale plus, OBTX has not sold more than 37,000 shares in a single day since it went public (there are currently only roughly 5 million shares OS). Even if he tried, he'd take years to sell all his shares at that volume and probably lose a ton of money.
So tell me again how he's going to take investor money.
Debunked Again
Where is the 24/7 cable news coverage?
People in glass houses shouldn't throw stones...
'I wish Ghislaine well, frankly': Trump sends extraordinary message of support to ex-neighbor Maxwell as she awaits trial for sex trafficking minors as the 'madam' of billionaire pedophile Jeffrey Epstein
Donald Trump has sent a message of support to Ghislaine Maxwell as pedophile billionaire Jeffrey Epstein's accused madam awaits her trial for sex trafficking minors.
The president admitted meeting Maxwell 'numerous times' over the years and wished her well in his Tuesday White House press conference - his first since vowing to return to coronavirus news briefings as cases soar across the US.
Trump's connections to Epstein and Maxwell have long come under scrutiny as they mixed in the same wealthy circles for decades, with Trump once describing the convicted pedophile as a 'terrific guy'.
Maxwell, 58, cried as she was denied bail on Tuesday and learned she must stay locked up until her trial next summer, after she pleaded not guilty to charges of luring underage girls so Epstein could sexually abuse them...
...Epstein's sprawling waterfront property in Palm Beach, where many of his victims said they were lured to and sexually abused, is just 1.8 miles down the road from Trump's Mar-a-Lago club.
In 1992, the future president organized a 'calendar girls' party with 28 women, with Epstein and himself the only men, according to Vanity Fair.
The two men were also seen on recently surfaced video footage partying together that year at Mar-a-Lago with cheerleaders from the Buffalo Bills.
In the footage, Trump is heard saying: 'Look at her… she's hot.'
In 1997, Trump also flew from Palm Beach to Newark, New Jersey, on Epstein's plane with Maxwell also aboard.
Now famous photos taken at Mar-a-Lago show the president posing with future First Lady Melania Trump, Epstein and Maxwell later in February 2000...
...Trump heaped praise on Epstein back then calling him a 'terrific guy' who likes women 'on the younger side'.
'He's a lot of fun to be with,' Trump said in an interview with Vanity Fair in 2002.
'It is even said that he likes beautiful women as much as I do, and many of them are on the younger side.'
Trump and Epstein reportedly fell out around 2004, in a dispute over a property purchase.
Four years later in 2018, Epstein pleaded guilty to one count of solicitation of prostitution and one count of solicitation of prostitution with a minor under the age of 18 and was sentenced to 18 months in jail.
The president has since sought to distance himself from Epstein and downplay his relationship with the pedophile.
One month before Epstein died in a New York jail cell in August last year, Trump said he was 'not a fan'.
'I had a falling out with him. I haven't spoken to him in 15 years,' Trump said at a White House press conference.
'I was not a fan of his, that I can tell you.'
Some of Epstein's victims have mentioned Trump and Mar-a-Lago in their accounts of events surrounding the abuse.
The president is mentioned in a civil suit filed by an unnamed woman who is suing Epstein's estate.
The alleged Epstein victim claims her abuser took her to Mar-a-Lago when she was just 14 and showed her to Trump.
She claims Epstein elbowed Trump 'playfully' and said: 'This is a good one, right?'
There is no suggestion Trump knew she was underage or was involved in any abuse.
Roberts Guiffre claims Epstein used Mar-a-Lago to prey on and recruit young girls into his sex-trafficking operation.
She claims she first met the pedophile as a 15-year-old working as a locker room attendant at Mar-a-Lago in 1999.
Newly resurfaced footage from 2015 also shows Trump telling reporters to ask Prince Andrew about Jeffrey Epstein's 'pedophile island'.
In in an interview with Bloomberg, Trump said: 'That island was really a cesspool, there's no question about it.
'Just ask Prince Andrew, he'll tell you about it. The island was an absolute cesspool.'
The connections between the pedophile and the president ramped up last month when Attorney General Bill Barr said Trump had ordered him to fire Geoffrey S. Berman, United States attorney for the Southern District of New York.
Berman's office charged Epstein with child sex trafficking last year.
Epstein was found hanging in his cell at the Metropolitan Correctional Center in Manhattan last August.
His death was ruled a suicide but his attorneys and some family members claim he was murdered to stop him from sharing what he knows about other high profile, powerful people.
Maxwell was denied bail last Tuesday and learned she must stay locked up until her sex trafficking trial in summer 2021.
She is now being held in a Brooklyn jail and pleaded not guilty last week to trafficking minors for Epstein.
Maxwell had been lying low since Epstein's death last year but was arrested earlier in the month, when authorities swooped on her luxury home in New Hampshire where prosecutors say she was hiding out.
She was romantically involved with the pedophile from around 1992, but then became his 'right-hand woman', managing his property empire and, it is alleged, his trafficking of minors.
Maxwell is currently in custody in the Metropolitan Detention Center in Brooklyn where she has been given paper clothes to prevent her committing suicide.
The "Net Loss" came almost completely from the award of preferred shares to the new management to establish controlling interest in the company...
Series A Preferred
As of April 30, 2020 and January 31, 2020, the company had 1,000,000 Series A Preferred shares, par value $0.0001, authorized, with 150,000 and 0 Series A Preferred shares issued and outstanding, respectively. The Series A Preferred stock converts into common stock after 2 years since its issuance. The conversion rate for every 1 share of Series A Preferred stock is 50 shares of common stock. The Series A Preferred stock votes 1,000 shares of common stock for every 1 share. Each share of Series A Preferred stock votes 1,000 shares of common stock, has no redemption rights, receives no dividends and has preference in dissolution over Common Stock.
During the quarter ending April 30, 2020 the Company sold 150,000 shares of Series A Preferred Stock to Epic Industry Corp at par value for a total payment of $15. Epic Industry Corp, through its sole shareholder directed the Company to issue 100,000 shares of Series A Preferred stock to Overwatch Partners, Inc., with the remaining 50,000 shares to Epic Industry Corp. The Company recorded the transaction at FMV of $40,137,788 with the difference assigned as stock-based compensation. The Company valued the stock under ASC 820 utilizing the Option Pricing Method to value conversion rights, and the Market Approach to value the voting control.
Series B Preferred
As of April 30, 2020 and January 31, 2020, the company had 1,000,000 Series B Preferred shares, par value $0.0001, authorized, with 650,000 and 0 Series B Preferred shares issued and outstanding, respectively. The conversion rate for every 1 share of Series B Preferred stock is 10 shares of common stock. Each share of Series B Preferred stock votes 50 shares of common stock, has no redemption rights, receives no dividends and has preference in dissolution over Common Stock and Series A Preferred.
During the quarter ending April 30, 2020, the Company issued 150,000 shares of Series B Preferred stock to Paul Rosenberg in exchange for 60 cryptocurrency ATM machines. Par value of $15 was recorded as inventory with the FMV of $6,548,188 minus the par value being recorded as stock-based compensation. The Company valued the stock under ASC 820 utilizing the Option Pricing Method to value conversion rights, and the Market Approach to value the voting control.
MCIG, Inc., converted 5,000,000 of its common shares into 500,000 shares of Series B Preferred stock...
...Our net loss from operations of $48,211,928 for the three months ended April 30, 2020 which consisted primarily of the stock-based compensation expense. With the exception of the stock-based compensation expense, we decreased our overall cost of operations in professional fees, consultant fees, and selling, general and administrative cost.
Obitx released their 1FQ21 10-Q thru 4/30/20 today...
OBTX 10-Q
Obitx released their 1FQ21 10-Q thru 4/30/20 today...
OBTX 1FQ21 10-Q
Some highlights...
No revenue, however, Mike Hawkins was named CEO on April 17 so there's virtually no record on his performance yet. Most of the news is contained in the following section...
Note 4. Related Party Transactions
The Company entered a Line of Credit with MCIG, for up to $500,000 in funding on November 1, 2016. The Line of Credit terminated on April 30, 2019. It was given at a 0% interest rate and is payable upon termination date with the option to convert the agreement into equity at a 15% discount to the then current market rate. The Line of Credit was reinstated and increased to $1,000,000 on January 1, 2018 and expired January 1, 2020. As of April 30, 2020, and January 31, 2020, the amount outstanding on the Line of Credit owed to MCIG was $218,257. (See Note 9 – Subsequent Events) The imputed interest of this line of credit for the three months ended April 30, 2020 was $3,779.
On June 14, 2018 the Company entered a Line of Credit with APO Holdings, LLC for up to $100,000 at any one time. The Line of Credit may be cancelled at any time by either party providing 30 days written notice of cancellation. It was given at a 0.6% monthly interest rate (7.2% annualized interest rate) and may be paid at any time with no definitive payoff date. During the quarter ended April 30, 2020 the Company received $5,644 under the Line of Credit. As of April 30, 2020, and January 31, 2020 the outstanding balance owed on the line of credit was $92,920 and $85,815, respectively. The accrued interest for the quarter ended April 30, 2020 and the year ended January 31, 2020 was $9,875 and $8,412 respectively. The interest expense for the three months ended April 30, 2020 was $1,461.
On April 17, 2020 the Company, issued 50,000 shares of Series A Preferred Stock to Epic Industry Corp and 100,000 shares of Series A Preferred Stock to Overwatch Partners, Inc for par value ($0.0001) for a total receipt of $15 paid by Epic Industry Corp. The Agreement was originally between the Company and Epic Industry Corp. The 100,000 shares of Series A Preferred was issued to Overwatch Partners at the discretion of Michael Hawkins, the sole owner of Epic Industry Corp. The Company’s CEO is 50% owner of Overwatch Partners. The issuance represents 33% of the Company’s stock on a fully diluted basis and 68% of voting control of the Company. (See Note 5 – Stockholder’s Equity – Preferred Stock). The Company valued the stock under ASC 820 utilizing the Option Pricing Method to value conversion rights, and the Market Approach to value the voting control. The issuance of stock’s recorded value was $40,137,788.
On April 17, 2020 the Company issued 150,000 shares of Series B Preferred Stock to Paul Rosenberg in exchange for 60 cryptocurrency ATM machines, which the Company believes has no retail or book value. The issuance represents 7% of the Company’s stock on a fully diluted basis. (See Note 5 – Stockholder’s Equity – Preferred Stock). The Company valued the stock under ASC 820 utilizing the Option Pricing Method to value conversion rights, and the Market Approach to value the voting control. The issuance of stock’s recorded value was $6,548,188.
During the three months ending April 30, 2020 Overwatch Partners paid multiple different expenses on behalf of the Company, which the Company treats as an accounts payable to related party. The total amount owed by the Company to Overwatch Partners as of April 30, 2020 was $7,601.
On April 22, 2020 the Company converted $104,987 outstanding accounts payable to Paul Rosenberg into 130,128 shares of common stock of the company at $0.75 per share. (See Note 5. Stockholder’s Equity).
On April 29, 2020 the Company converted 5,000,000 shares of common stock owned by MCIG, Inc., into 500,000 shares of Series B Preferred stock. MCIG is restricted from converting the Series B Preferred stock into common stock for a period of 24 months from the conversion. There was no gain or loss on conversion due to conversion terms (see Note 5).
I'm keeping an open mind, particularly since I don't pretend to be an expert on cryptocurrency. However, your analysis has a significant flaw, You conflate BIT tokens with BIT coins. First Bitcoins currency is a coin whose value can be tracked at...
First Bitcoin BIT - coinmarketcap.com
There's also a token with the same name - BIT (aka Block Estate) and a different value. I suspect this was the value used in your analysis.
Token vs Coin — what’s the difference?
Two terms used to describe units of blockchain value are COIN and TOKEN. Their meaning and usage overlaps considerably and they are often used interchangeably, but — strictly speaking, at least — there are some differences.
Function vs form
Very broadly, a crypto coin is just that: a coin, or means of payment, whilst a token has wider functionality. The express purpose of a coin is to act like money: as a unit of account, store of value and medium of transfer...
...Blockchain tokens do have value, but they cannot be considered money in quite the same way that a straightforward coin can.
I reviewed your links and found a lot of inuendo but little concrete evidence of any wrongdoing. The critique seems to rest on improper valuation of the BIT coins used in the loans. However, looking at the historical data on Coinmarketcap.com, the BIT value seems to be accurate.
What seems questionable to me is that currently, there doesn't seem to be enough trading volume to support redemption of a significant number of BIT coins. However, if I'm not mistaken, it could be converted to BTC which could then be cashed. Moreover, if BTZI's plan to give a dividend is successful, or if many more ATM's are installed, there will be a lot more BIT in circulation in the future, thus solving that problem.
If First Bitcoin plan was to have Bots become their vehicle for valuing their assets, the plan may succeed. The 600,000,000 BIT coins that KNOS received for their $1,000,000 note would be worth $3,732,600 at today's market valuation of $.006221/BIT...
Coinmarketcap.com First Bitcoin BIT
On December 31, 2018 BIT was valued at roughly $.0018 so...
$.0018 x 600,000,000 BIT = $1,080,000
If you look at the July 13 BTZI PR...
BOTS, Inc. Completes Acquisition of Majority Ownership in First Bitcoin Capitals Crypto Assets
...it states that BTZI acquired...
$1,250,000 in face value Convertible Promissory Notes issued by Kronos Advanced Technologies to First Bitcoin Capital LLC.;
Thanks for the clarification.
It's unclear from the available information where those ATM's came from. First Bitcoin could have acquired them when they acquired their ATM Kiosk Patent. Their January 2020 Form 20F states that they have a subsidiary named "Bitcoin ATM Franchise Holdings Corp.". I would think they might own some ATM's, or they could have purchased the ATM inventory from Paul or simply acted as a sales agent for Paul to sell the ATM's to KNOS.
In any event, I suspect the ATM's will eventually end up with the subsidiary, Bitcoin ATM Franchise Holdings.
Please list the source of your quote. Is that note from a Bots, First Bitcoin or Kronos financial??? Who is "the Company"?
FYI all posters: It's easy to provide a link to your quotes. Please put the link into your post, highlight it, then click on the "Url" button on the left. Replace the text between the [tag] and [/tag] with a description of the link (e.g. "Bots, Inc. 10-K"). That description will then be a link to your quote source. Quotes can also be designated by simply highlighting the quote and clicking on the quote button on the left before you submit the post.
I honestly don't know. We haven't spoken since February. He's still CEO but First Bitcoin management will be the largest shareholder and eventually have 50% voting control. It seems apparent that Paul's role will be somewhat diminished as decisions will at least need the tacit approval of First Bitcoin.
The ATM's ended up with Paul. According to the financials, he took them as payment of debt that mCig owed him. There's no reason he can't sell them back if needed or sell them to ATM franchisees.